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An anthropomorphic Phantom, a female trunk, was built with a natural bone structure and experimental material coated, glycerin and water-
based material called JJT to build soft tissue equivalent to the muscle of human tissue, and a polymer (styrofoam) to build the lung as critical
organ to simulate the treatment of breast cancer, with high dose rate brachytherapy (HDR) and sources of Ir-192. The treatments were planned
and calculated for the critical organ: Lung, and injury of 2 cm in diameter in breast with MicroSelectron HDR system and the software Plato
Brachytherapy V 14.1 of the Nucletron (Netherlands) which uses the standard protocol of radiotherapy for brachytherapy treatments. The
dose experimentally measured with dosimeters TLD-100 LIF: Mg; Ti, which were previously calibrated, were placed in the same positions
and bodies mentioned above, with less than 5% uncertainty. The reading dosimeters was carried out in a Harshaw TLD 4500.The results
obtained for calculated treatments, using the standard simulator, and the experimental with TLD-100, show a high concordance, as they are
on average a ± 1.1% making process becomes in a quality control of this type of treatments.
Keywords: TLD-100; anthropomorphic phantom; brachytherapy HDR; breast.
PACS: 87.53. Jw; 87.66.Xa; 87.66.Sq
1. Introduction
In the use of ionizing radiation in medicine, (radiother-
apy, diagnostic radiology, nuclear medicine), is indispens-
able knowledge of the absorbed dose given to the patient and
their determination should be very rigorous, so the Interna-
tional Commission of Radiological Units (ICRU) in its report
59 [2,5] recommends an accuracy of ±5% in the administra-
tion of the absorbed dose in the target volume if the main ob-
jective is the elimination of the primary tumor with the least
possible damage to nearby healthy tissue, as is the radiation
therapy. It is necessary to know the physical characteristics
of the sources of ionizing radiation used in certain treatments,
with which defines the conditions for using certain dosimetry
system [3]. In this work, of interstitial brachytherapy, ther-
moluminescent dosimeters TLD-100 were used for present-
ing the following features: rods shape, size of 1.1 mm diam-
eter and 6 mm in length, high precision, good environmen-
tal stability and human tissue equivalence, a wide sensitivity
range good spatial resolution [1], which is vital for this type
of dosimetry given the appearance of high-dose gradients in
the implementation of treatments of high-dose brachytherapy
in breast tumors. The objective of this work is to build an an-
thropomorphic phantom that allows ensuring the quality of
the interstitial breast treatments, i.e., control and estimation
of the dose prescribed, using high dose rate and detectors
TLD-100. The paper is organized as follows. In Sec. 2 and
in the subsections therein, the general methodology is pre-
sented. The construction of the anthropomorphic phantom,
based on the natural bone structure and material JJT, also
present the planning of the treatments. The calibrations of
the dosimeters (TLD-100) are presented in Sec. 3, with em-
phasis on the Co- 60. Results and discussion are presented in
Sec. 4. The conclusions are presented in section Sec. 5.
2. Methodology
Build an anthropomorphic phantom, requires that the mate-
rial used is equivalent, biologically, to human muscle tissue,
in our case the Simulator was built using a natural bone struc-
ture corresponding to the chest of a 42-year-old woman, av-
erage age of patients treated at the Instituto Nacional de Can-
cerologı´a (INC), Colombia. The phantom is shown in Figs. 1
and 2.
2.1. Construction of the anthropomorphic phantom
The experimental material, used in construction breast and
lining of the chest is according to the specifications of the
ICRU 44. [5], constituent elements of our anthropological
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FIGURE 1. Natural bony structure of the torax used in the construc-
tion of the antropomorphic phantom.
FIGURE 2. Antropological phantom with the respective breast im-
plant for the treatment of high dose rate.
phantom as shown in Fig. 2 , was subjected to a physical,
chemical, and radiological analysis by J. Va´squez et al. [4],
whose results show that JJT material is suited to be used as
replacement tissue and the construction of anthropological
phantom.
2.2. Calibration of TLD- 100 Crystals with the energy
of Co-60
With the energy of Co 60, the crystals were irradiated with a
dose of 50 cGy in a Theratron 780, using a field of reference
of size 10 × 10 cm2, and sensitizing with five irradiations,
without performing readings interspersed with an anneling
from 1 hour to 400◦C followed by two hours at 100◦C, at
intervals of 12 hours irradiation [6]. To carry out this heat
treatment was used oven Lindberg/Blue UP150. In order to
calculate the dose is proceeded according to:
D =MNcalKchipKlinKSSDKfield (1)
where D is the dose read on the crystals, M is the reading in
coulomb (C) of the crystals. This process was held with the
FIGURE 3. Calibration of TLD-100 with Co 60(average energy
1.25 MeV).
reader Harshaw TLD 4500, manufactured by Bicron using
for this purpose the planchet heating equipment. During the
process a preheat temperature of 50◦C was used, from which
the data acquisition is performed, at a rate of 10◦Cs until
reaching a maximum temperature of 300◦C, followed by an-
nealing at 300◦C . To eliminate the contribution due to in-
frared heating and reducing the effects of moisture during the
process, all readings were carried out on a atmosphere of high
purity N2. Ncal is the conversion factor for units of Coulomb
(C) in dose units (Gy); Kchip is the ratio between the aver-
age reading of crystals and individual reading of each crystal,
Klin is the correction factor for the nonlinear response of the
Crystal with the dose, KSSD is the correction factor due to the
distance source -surface; Kfield is the correction factor due to
the size of the field. Calculated performance shows a high
correlation with that used in the calculation Prowess of the
Instituto Nacional de Cancerologı´a (INC) program and the
calculated time to deposit the dose of 50 cGy was 0.59 min-
utes the date of calibration. The next process was radiate,
with specific dosage, groups of 4 crystals, obtaining an aver-
age reading for each group of crystals. The Fig. 3 shows the
curve obtained according to the readings of the TL signals of
the crystals, with a squared correlation coefficient r2 = 0.999
and given by the equation:
DL = 34 cGy + 3.7
cGy
µC
L(µC). (2)
Where DL is the calculated dose and L is the reading of the
Crystal.
2.3. Calibration of the TLD with the energy of Ir - 192
(0.38 MeV)
Connected a 6F endobronchial catheter to the HDR unit so
that through it the source Ir-192 will be moved and thus to
determine their point of positioning which was verified with
an X-ray image. The crystals were placed in groups of four
with a buildup of 2 mm material thickness JJT, on the trans-
verse axis of the source at a distance of 10 cm [7]. Supplied
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FIGURE 4. Calibration of TLD-100 with Ir 192 (average energy
0.38 MeV).
doses varied in the range of 300 to 750 cGy, obtaining the
curve shown in Fig. 4, with a quadratic correlation coeffi-
cient r2 = 0.998 and equation given by:
DL = 44.2 cGy + 14.4
cGy
µC
L(µC). (3)
Where DL is the calculated dose and L is the reading of the
crystal.
2.4. Treatments Planning
It was implanted in the anthropomorphic phantom the system
consisting of two external fixing strips of 80 mm in length
and 3.5 mm thick, each one, and twelve needles vector of
stainless steel 120 mm in length, as shown in Fig. 2. Is ver-
ified the correct location of the implant using fluoroscopy.
Catheters were introduced with fictitious sources in the pre-
scription points, located between the two central needles and
5 mm deep level below it in order to determine the placement
FIGURE 5. Computed axial tomography used for the location of
the crystals in the anthropomorphic phantom.
FIGURE 6. Isodose curves for interstitial breast treatments with
nine needles for vector doses between 400 to 700 cGy
points of the crystals where the dose is measured, as shown
of red color in Fig. 5.
Treatments made planning for a range of doses between
400-700 cGy, for a tumor volume 5.56 cm3 and taking into
account the spatial coordinates of each of the needles, so cal-
culate with the planning system, Plato Brachytherapy [8], the
isodose curves which are shown in Fig 6.
3. Results and discussions
Figure 4 which represents the calibration of the TL crystals
with source Ir - 192 shows that the crystals have a linear be-
havior in the dose range of 300-750 cGy, Which is in good
agreement with the works done by S.W.S McKeever et al and
J.L Mun˜iz [12, 13], the background radiation present may be
related to factors such as high relative humidity (70%) and
room temperature (30◦C), where the calibration was done.
The validation of the method used in the earlier results was
made with a group of dosimeters whose values are shown in
Table I, whereDsystem is the calculated dose with the planning
system Plato Brachytherapy. According to Table I the max-
imum difference between the measured dose with the TLD-
100 and the calculated dose with the planning system is
TABLE I. Validation of the method of calibration of dosimeters
TLD-100 with Ir-192.
Dsystem(cGy) DL(cGy) DLDsystem
300 296.9 0.986
350 345.5 0.987
400 396.6 0.991
450 444.5 0.987
500 491.4 0.987
550 542.9 0.992
600 595.8 0.993
650 645.5 0.99
700 692.0 0.988
750 745.1 0.993
Rev. Mex. Fis. 60 (2014) 409–413
412 F. TORRES HOYOS, NICOL ´AS DE LA ESPRIELLA V ´ELEZ AND ALVARO S ´ANCHEZ CARABALLO
TABLE II. Comparison of the calculated dose with the planning
system and measures with TLD - 100 in the treatment of breast.
Dsystem(cGy) DTLD(cGy) DTLDDsystem
700 673 0.961
650 637 0.980
600 584 0.973
500 487 0.974
400 393 0.982
FIGURE 7. Glow Curve of TLD - 100 at a heating rate of 1◦C/s
between 50 and 300◦C
1.4 %, results that are within the range of validity for this type
of procedure [9].
The Table II compares the calculated doses with the plan-
ning system and the measures with the TLD -100 in the treat-
ments prescribed breast between the center two needles of
the deep level and 5 mm below the same. Table II shows that
the maximum difference between the dose measurement with
the TLD - 100 and calculated by the planning system differs
by 4%, which is consistent with the expressed in the ARCAL
XXX for this type of treatment [9].
As the dosimeters were reused, it was observed that its
sensitivity varied, this is due to surface effects, since it can be
given several mechanisms affecting TL sensitivity. The most
important are the changes in light transmission due to con-
tamination, scratches and gaseous absorption can also alter
the intrinsic efficiency or lead to no radiation-induced signals.
Another possible cause may be largely the spatial distribution
of the concentration of traps. As defects are dependent on the
level of impurities in parts per million and, to a lesser extent,
on their heating and thermal history, it is very difficult to set
the properties of a TL material. This leads to batch effects.
For optimum precision calibrations must be performed for
each individual dosimeter. [1,10]. Dosimeters irradiated per-
manently keep all information provided, resulting in a grad-
ual loss of dormant thermoluminescence signal. This should
be corrected prior to the assessment being adopted heat treat-
ments.
Figure 7 shows the glow curve of one of TLD - 100 (LiF:
Mg, Ti) used, the reading was made at a heating rate of 1◦C/s,
in the temperature interval [50-300]◦C. To observe a better
definition of the peaks of the crystal was done a simplified
analysis with the WinREMS program which is able to solve
a complex curve of thermoluminescence and adjust the ex-
perimental points using the kinetic theory of first order [13]
the result of this analysis is the clearly defined the peaks 2, 3,
4 and 5.
The use of pre- irradiation annealing to eliminate al-
most completely the picks 2 and 3, significantly increases
the peaks 4 and 5, therefore, to eliminates post- irradiation
fading in TLD -100. The correlation between peaks 2, 3 and
peak 5 led Cameron et al [1]to suggest that peaks 2 and 3 are
associated with (Mg2+) dipoles while suggesting that peak
5 is a higher order cluster of three dipoles (trimer). More
recently, it has been suggested that the trimer is spatially
correlated with (Ti+3) ions to form an even larger trapping-
recombination complex [14].
4. Conclusions
In this work of quality control of the treatments of breast
Ca with HDR dosimetry using TLD - 100 were simulated
ten cases for prescribed dose. The results of the dose mea-
sures show great similarity with to those calculated with the
planning system Plato BRACHYTHERAPY V. 14.1 because
they present a maximum difference of 4% , which makes it
a good quality control system for treatments of HDR inter-
stitial brachytherapy which allows us to affirm that the pre-
scribed doses are given correctly to the patients and do not
exceed the dose of tolerance for breast [9, 11]. The calibra-
tion curve of crystals in material JJT, with the average energy
of the Ir - 192, with a buildup of 2 mm and distance source
crystal 10 cm, show good results to determine the dose in
the range of 0 to 1000 cGy, implying that the dosimetry tech-
nique is effective provided that thermal processes for this type
of dosimetry are followed [9].
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